High Liver Fat (Hepatic Steatosis) Linked to Increased Risk of Hospitalization in COVID-19 Patients With Obesity admin Wed, 03/31/2021 - 15:32
source https://www.pharmatutor.org/pharma-news/2021/high-liver-fat-hepatic-steatosis-linked-to-increased-risk-of-hospitalization-in-covid-19-patients-with-obesity
Subscribe to:
Post Comments (Atom)
Pharmaceutical Industry and pharma / Life Sciences institute openings 2025
Intas Pharma Walk in Drive for M.Pharm, B.Pharm | Multiple Posts M.Pharma / B.Pharma. Injectable/Parenteral/Sterile - Aseptic, Manufacturi...
-
Results from a clinical trial published in 2011 confirmed the benefit of using Avastin over laser therapy for treating the most severe c...
-
The National Institutes of Health announced a new initiative aimed at speeding innovation, development and commercialization of COVID-19...
-
Clinical Development Services Agency (CDSA) is an extramural unit of Translational Health Science and Technology Institute (THSTI) and ha...
No comments:
Post a Comment